News
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 and June 3 was host to the Poster Session: Genitourinary Cancer - Prostate, ...
Surgery risks have been highlighted in a new warning for users of popular diabetes and weight-loss drugs, including Ozempic ...
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max response rates have not yet been observed; strict continuation criteria at three months in this ...
(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Rana McKay discussing the molecular and clinical characterization of KLK2 mRNA expression in ...
Men’s Health Month 2025 encourages men to adopt preventive care and healthy lifestyle habits to improve overall health ...
Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...
Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) , Milan, have found that gene editing using CRISPR-Cas9 in combination ...
Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and ...
12h
Pharmaceutical Technology on MSNFDA grants expanded access to ImmunityBio’s Anktiva for lymphopeniaAnktiva is designed to address BCG-unresponsive bladder cancer through its mechanism as an interleukin-15 superagonist.
The investigational drug demonstrated robust STAT6 degradation in blood and skin that was well tolerated and safe in healthy ...
B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results